Guidelines for identification and treatment of individuals with attention deficit/hyperactivity disorder and associated fetal alcohol spectrum disorders based upon expert consensus
MetadataShow full item record
Background: The association of attention deficit/hyperactivity disorder (ADHD) and fetal alcohol spectrum disorders (FASD) results in a complex constellation of symptoms that complicates the successful diagnosis and treatment of the affected individual. Current literature lacks formal guidelines, randomized control trials, and evidence-based treatment plans for individuals with ADHD and associated FASD. Therefore, a meeting of professional experts was organized with the aim of producing a consensus on identification and treatment guidelines that will aid clinicians in caring for this unique patient population. Methods: Experts from multiple disciplines in the fields of ADHD and FASD convened in London, United Kingdom, for a meeting hosted by the United Kingdom ADHD Partnership (UKAP; www.UKADHD.com) in June 2015. The meeting provided the opportunity to address the complexities of ADHD and FASD from different perspectives and included presentations, discussions, and group work. The attendees worked towards producing a consensus for a unified approach to ADHD and associated FASD. Results: The authors successfully came to consensus and produced recommended guidelines with specific regards to identification and assessment, interventions and treatments, and multiagency liaisons and care management, highlighting that a lifespan approach to treatment needs to be adopted by all involved. Included in the guidelines are: 1) unique ‘red flags’, which when identified in the ADHD population can lead to an accurate associated FASD diagnosis, 2) a treatment decision tree, and 3) recommendations for multiagency care management. Conclusions: While clinically useful guidelines were achieved, more research is still needed to contribute to the knowledge base about the diagnosis, treatment, and management of those with ADHD and associated FASD.
Showing items related by title, author, creator and subject.
Recommendations from a consensus development workshop on the diagnosis of fetal alcohol spectrum disorders in AustraliaWatkins, R.; Elliott, E.; Wilkins, A.; Mutch, R.; Fitzpatrick, J.; Payne, J.; O'Leary, Colleen marie; Jones, H.; Latimer, J.; Hayes, L.; Halliday, J.; D'antoine, Heather; Miers, S.; Russell, E.; Burns, L.; McKenzie, A.; Peadon, E.; Carter, M.; Bower, C. (2013)Abstract Background: Fetal alcohol spectrum disorders (FASD) are underdiagnosed in Australia, and health professionals have endorsed the need for national guidelines for diagnosis. The aim of this study was to develop ...
Watkins, R.; Elliott, E.; Halliday, J.; O'Leary, Colleen marie; D'antoine, Heather; Russell, E.; Hayes, L.; Peadon, E.; Wilkins, A.; Jones, H.; McKenzie, A.; Miers, S.; Burns, L.; Mutch, R.; Payne, J.; Fitzpatrick, J.; Carter, M.; Latimer, J.; Bower, C. (2013)Background: There is little reliable information on the prevalence of fetal alcohol spectrum disorders (FASD) in Australia and no coordinated national approach to facilitate case detection. The aim of this study was to ...
Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skillsBihlar Muld, B.; Jokinen, J.; Bolte, Sven; Hirvikoski, T. (2013)Background: Attention Deficit/Hyperactivity Disorder (ADHD) is associated with an increased risk of co-existing substance abuse. The Swedish legislation on compulsory healthcare can be applied to persons with severe ...